Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Nuclear Medicine Institute of Fudan University, Shanghai, China.
J Nucl Med. 2022 Jun;63(6):959-965. doi: 10.2967/jnumed.121.262038. Epub 2021 Sep 30.
The present study aimed to evaluate the feasibility of ultra-low F-FDG activity in total-body PET/CT oncologic studies. Thirty patients with cancer were enrolled prospectively and underwent a total-body PET/CT scan 60 min after injection of an ultra-low F-FDG activity (0.37 MBq/kg). Of the 30 enrolled patients, 11 were diagnosed with colorectal cancer (CRC). PET raw data were acquired within 15 min and reconstructed using data from the first 1, 2, 4, 8, and 10 min and the entire 15 min (G1, G2, G4, G8, G10, and G15, respectively). Image quality was qualitatively assessed twice by 2 readers using a 5-point Likert scale. The Cohen κ-test was used to investigate the intra- and interreader agreement. The SUV of lesions; the SUV, SUV, and SD of the livers; the tumor-to-background ratio; and the signal-to-noise ratio were measured and compared. The acquisition time for a clinically acceptable image quality using an ultra-low-activity injection was determined. In a matched-pair study, 11 patients with CRC who received a full F-FDG activity (3.7 MBq/kg) with an acquisition time of 2 min were selected retrospectively by matching sex, height, weight, body mass index, glucose level, uptake time, and pathologic types with the 11 CRC subjects in the prospective study. Qualitative and quantitative analyses were performed and compared between the 11 patients with CRC in the ultra-low-activity group and their matched full-activity controls. Qualitative analysis of image quality showed good intra- and interreader agreements (all κ > 0.7). All the images acquired for 8 min or longer scored over 3 (indicating clinical acceptability). There was no significant difference in tumor-to-background ratio and liver signal-to-noise ratio among all the images acquired for 8 min or longer. In the matched study, no significant difference was found in the image quality score and quantitative parameters between the ultra-low-activity group with an 8-min acquisition and the full-activity group with a 2-min acquisition. An ultra-low F-FDG activity with an 8-min acquisition in a total-body PET/CT study can achieve acceptable image quality equivalent to that in the full-activity group after a 2-min acquisition.
本研究旨在评估全身 PET/CT 肿瘤研究中超低 F-FDG 活性的可行性。前瞻性纳入 30 例癌症患者,在注射超低 F-FDG 活性(0.37MBq/kg)后 60 分钟行全身 PET/CT 扫描。30 例入组患者中,11 例诊断为结直肠癌(CRC)。在 15 分钟内采集 PET 原始数据,并使用第 1、2、4、8 和 10 分钟以及整个 15 分钟的数据进行重建(分别为 G1、G2、G4、G8、G10 和 G15)。由 2 位读者使用 5 分制李克特量表进行两次定性评估。采用 Cohen κ 检验评估读者内和读者间的一致性。测量并比较了病变的 SUV、肝脏的 SUV、SUV 和 SD、肿瘤与背景比以及信噪比。确定了使用超低活性注射获得可接受图像质量的采集时间。在一项匹配对研究中,回顾性选择了 11 例接受全 F-FDG 活性(3.7MBq/kg)并在 2 分钟内采集的 CRC 患者,其性别、身高、体重、体重指数、血糖水平、摄取时间和病理类型与前瞻性研究中的 11 例 CRC 患者相匹配。对 11 例超低活性组和全活性对照组的 CRC 患者进行了定性和定量分析。图像质量的定性分析显示出良好的读者内和读者间一致性(所有 κ>0.7)。所有采集 8 分钟或更长时间的图像评分均超过 3(表示临床可接受性)。采集 8 分钟或更长时间的所有图像的肿瘤与背景比和肝脏信噪比均无显著差异。在匹配研究中,采集 8 分钟的超低活性组与采集 2 分钟的全活性组之间的图像质量评分和定量参数无显著差异。全身 PET/CT 研究中采集 8 分钟的超低 F-FDG 活性可获得与采集 2 分钟的全活性组相当的可接受的图像质量。